Evidence map›Paper›PMID 34307269›Full record

SynthesisFrontiers in public health2021

Efficacy of Integrated Traditional Chinese and Western Medicine for Treating COVID-19: A Systematic Review and Meta-Analysis of RCTs.

Bei Yin, Yi-Ming Bi, Lu Sun, Jin-Zhu Huang, Jia Zhao, Jia Yao, An-Xiang Li, Xian-Zhe Wang, Guan-Jie Fan

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Frontiers in public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Herbal medicine for COVID-19: An overview of systematic reviews and meta-analysis.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2022
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Bei YinSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Yi-Ming BiSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Lu SunSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jin-Zhu HuangSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jia ZhaoSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Jia YaoSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
An-Xiang LiSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Xian-Zhe WangSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guan-Jie FanSchool of Second Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
Guangzhou University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Drugs, Chinese HerbalIntegrative MedicineChinaHumansRandomized Controlled Trials as TopicSARS-CoV-2Drugs, Chinese HerbalCOVID-19efficacyintegrated Chinese and Western medicinemeta-analysissystematic review

Identifiers

PMID34307269
PMCPMC8298033
OpenAlexW3182771209

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.